Mark L. Berch

Array ( [id] => 6071256 [patent_doc_number] => 20110046107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'SULFONYL-SUBSTITUTED CARBAPENEM COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/672854 [patent_app_country] => US [patent_app_date] => 2008-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14182 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046107.pdf [firstpage_image] =>[orig_patent_app_number] => 12672854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792731 [patent_doc_number] => 20080293705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'A1 ADENOSINE RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/186857 [patent_app_country] => US [patent_app_date] => 2008-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8629 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293705.pdf [firstpage_image] =>[orig_patent_app_number] => 12186857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792774 [patent_doc_number] => 20080293748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Thioxanthine Derivatives as Myeloperoxidase Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/185158 [patent_app_country] => US [patent_app_date] => 2008-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13345 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293748.pdf [firstpage_image] =>[orig_patent_app_number] => 12185158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8690193 [patent_doc_number] => 08389722 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Adefovir dipivoxil crystalline monohydrate form' [patent_app_type] => utility [patent_app_number] => 12/671556 [patent_app_country] => US [patent_app_date] => 2008-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 808 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12671556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5361878 [patent_doc_number] => 20090036672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'INTERMEDIATE CEFDINIR SALTS' [patent_app_type] => utility [patent_app_number] => 12/181438 [patent_app_country] => US [patent_app_date] => 2008-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4141 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20090036672.pdf [firstpage_image] =>[orig_patent_app_number] => 12181438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840606 [patent_doc_number] => 20080281092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use' [patent_app_type] => utility [patent_app_number] => 12/219196 [patent_app_country] => US [patent_app_date] => 2008-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14724 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20080281092.pdf [firstpage_image] =>[orig_patent_app_number] => 12219196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5350039 [patent_doc_number] => 20090005400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'Biologically Active Aphrocallistin Compounds' [patent_app_type] => utility [patent_app_number] => 12/165304 [patent_app_country] => US [patent_app_date] => 2008-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4554 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20090005400.pdf [firstpage_image] =>[orig_patent_app_number] => 12165304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5416966 [patent_doc_number] => 20090042853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'PENEM PRODRUGS' [patent_app_type] => utility [patent_app_number] => 12/164818 [patent_app_country] => US [patent_app_date] => 2008-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8189 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042853.pdf [firstpage_image] =>[orig_patent_app_number] => 12164818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853240 [patent_doc_number] => 20080318983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'A2B ADENOSINE RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/147382 [patent_app_country] => US [patent_app_date] => 2008-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 36224 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318983.pdf [firstpage_image] =>[orig_patent_app_number] => 12147382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446023 [patent_doc_number] => 20090047249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Modulators of toll-like receptor 7' [patent_app_type] => utility [patent_app_number] => 12/215598 [patent_app_country] => US [patent_app_date] => 2008-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36348 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20090047249.pdf [firstpage_image] =>[orig_patent_app_number] => 12215598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6327328 [patent_doc_number] => 20100197653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'NOVEL CARBAPENEM DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/666977 [patent_app_country] => US [patent_app_date] => 2008-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11779 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197653.pdf [firstpage_image] =>[orig_patent_app_number] => 12666977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682863 [patent_doc_number] => 20080249089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => '8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/143128 [patent_app_country] => US [patent_app_date] => 2008-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52505 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249089.pdf [firstpage_image] =>[orig_patent_app_number] => 12143128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4664252 [patent_doc_number] => 20080255159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => '8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/143219 [patent_app_country] => US [patent_app_date] => 2008-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52505 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255159.pdf [firstpage_image] =>[orig_patent_app_number] => 12143219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4760085 [patent_doc_number] => 20080312311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Crystalline forms of 3-(2R-tetrahydrofuryl-methyl)-2-thioxanthine' [patent_app_type] => utility [patent_app_number] => 12/137583 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7352 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312311.pdf [firstpage_image] =>[orig_patent_app_number] => 12137583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5331297 [patent_doc_number] => 20090111774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'PMEA LIPID CONJUGATES' [patent_app_type] => utility [patent_app_number] => 12/130911 [patent_app_country] => US [patent_app_date] => 2008-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13915 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20090111774.pdf [firstpage_image] =>[orig_patent_app_number] => 12130911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558775 [patent_doc_number] => 20090270352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'Tenofovir Disoproxil Hemi-Fumaric Acid Co-Crystal' [patent_app_type] => utility [patent_app_number] => 12/301872 [patent_app_country] => US [patent_app_date] => 2008-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12155 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270352.pdf [firstpage_image] =>[orig_patent_app_number] => 12301872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960522 [patent_doc_number] => 20080274947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Hydroxy-Substituted Diphenylazetidinones for the Treatment of Hyperlipidemia' [patent_app_type] => utility [patent_app_number] => 12/122991 [patent_app_country] => US [patent_app_date] => 2008-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14104 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274947.pdf [firstpage_image] =>[orig_patent_app_number] => 12122991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840350 [patent_doc_number] => 20080280836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Anti-hypercholesterolemic biaryl azetidinone compounds' [patent_app_type] => utility [patent_app_number] => 12/151647 [patent_app_country] => US [patent_app_date] => 2008-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21354 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280836.pdf [firstpage_image] =>[orig_patent_app_number] => 12151647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840613 [patent_doc_number] => 20080281099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'PROCESS FOR PURIFYING VALACYCLOVIR HYDROCHLORIDE AND INTERMEDIATES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/116277 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6655 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20080281099.pdf [firstpage_image] =>[orig_patent_app_number] => 12116277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4728368 [patent_doc_number] => 20080207912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Method for manufacture of ceftiofur' [patent_app_type] => utility [patent_app_number] => 12/150744 [patent_app_country] => US [patent_app_date] => 2008-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6761 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207912.pdf [firstpage_image] =>[orig_patent_app_number] => 12150744 [rel_patent_id] =>[rel_patent_doc_number] =>)